Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Cortisol Resistance in Men
NCT01294319Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Jan 2011
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mifepristone, spironolactone, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Jan 2011; status: completed.
02
Drugs
mifepristonespironolactone
Beyond the preview
Go deeper on NCT01294319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294319.